NOV 11, 2015 03:00 PM PST

Proposed Rule for the Medicare Clinical Diagnostic Laboratory Test Payment System

Speakers
  • President, Medical Technology Partners
    Biography
      Jerry Stringham has worked as a reimbursement strategy consultant since the 1980s, when he began providing reimbursement consulting to diverse medical and pharmaceutical companies. Jerry holds a BS in mechanical engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. He has been part of five medical device start-up organizations operating out of New England and has grown MTP's client list to over 140 clients. Jerry founded Medical Technology Partners in 1998 to fill the growing need for business-oriented reimbursement consulting. Jerry's experience in industry, including as a Principal in the health economics practice of a major CRO, brings expertise to new technology reimbursement challenges.

    Abstract:

    Medical Technology Partner’s presentation is designed highlight what Medicare is proposing to do based on the Protecting Access to Medicare Act of April 1, 2014 with regard to clinical laboratory diagnostic tests in general and Laboratory Developed Tests in particular.

    This presentation’s learning objectives are to alert participants that there are:

    • Upcoming proposed changes in how Medicare proposes to pay for Clinical Diagnostic Laboratory Tests (CLDTs)
    • Key reimbursement proposals that could affect Laboratory Developed Tests (LDTs)
    • Easy ways to access the CMS source document and respond before  November 24, 2015

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    Loading Comments...